[144] Idexx Laboratories Inc SEC Filing
Idexx Laboratories insider transaction disclosed via Form 144. The filing reports a proposed sale of 1,200 common shares through Morgan Stanley Smith Barney with an aggregate market value of $787,840.20. The shares were acquired by exercise on 08/06/2025 and payment was made in cash. With 80,004,694 shares outstanding, the proposed sale represents approximately 0.0015% of the company鈥檚 outstanding common stock.
The filing also lists three sales by NIMRATA K HUNT on 08/06/2025 totaling 7,143 shares and gross proceeds of $4,503,160.86. The filer affirms they are not aware of any material nonpublic adverse information about the issuer.
Operazione insider di Idexx Laboratories comunicata tramite Form 144. La comunicazione segnala la proposta vendita di 1,200 azioni ordinarie tramite Morgan Stanley Smith Barney per un valore di mercato complessivo di $787,840.20. Le azioni sono state acquisite mediante esercizio il 08/06/2025 e il pagamento 猫 stato effettuato in contanti. Con 80,004,694 azioni in circolazione, la vendita proposta rappresenta circa 0.0015% del capitale ordinario della societ脿.
La comunicazione riporta inoltre tre vendite a nome di NIMRATA K HUNT in data 08/06/2025 per un totale di 7,143 azioni e proventi lordi pari a $4,503,160.86. Il dichiarante afferma di non essere a conoscenza di informazioni riservate negative rilevanti sull'emittente.
Operaci贸n de insider de Idexx Laboratories divulgada mediante Form 144. El informe comunica la propuesta venta de 1,200 acciones ordinarias a trav茅s de Morgan Stanley Smith Barney por un valor de mercado agregado de $787,840.20. Las acciones se adquirieron mediante ejercicio el 08/06/2025 y el pago se realiz贸 en efectivo. Con 80,004,694 acciones en circulaci贸n, la venta propuesta representa aproximadamente el 0.0015% del capital social ordinario de la compa帽铆a.
El expediente tambi茅n recoge tres ventas efectuadas por NIMRATA K HUNT el 08/06/2025 por un total de 7,143 acciones y unos ingresos brutos de $4,503,160.86. El declarante afirma no tener conocimiento de informaci贸n adversa material no p煤blica sobre el emisor.
Form 144毳� 韱淀暣 瓿奠嫓霅� Idexx Laboratories 雮措秬鞛愱卑霝�. 鞝滌稖靹滊鞐� 霐半ゴ氅� Morgan Stanley Smith Barney毳� 韱淀暣 齑� 鞁滌灔臧�旃� $787,840.20 靸侂嫻鞚� 1,200 氤错喌欤� 毵り皝鞚� 鞝滌晥霅橃棃鞀惦媹雼�. 頃措嫻 欤检嫕鞚� 08/06/2025鞐� 頄夓偓毳� 韱淀暣 旆摑霅橃棃鞙茧┌ 雽�旮堨潃 順勱笀鞙茧 歆�攵堧悩鞐堨姷雼堧嫟. 氚滍枆欤检嫕 靾橁皜 80,004,694欤检澑 臧�鞖措嵃 鞝滌晥霅� 毵り皝鞚� 須岇偓 氤错喌欤� 齑濎垬鞚� 鞎� 0.0015%鞐� 頃措嫻頃╇媹雼�.
霕愴暅 鞝滌稖靹滊鞐愲姅 NIMRATA K HUNT臧� 08/06/2025鞐� 齑� 7,143欤茧ゼ 毵り皝頃橃棳 齑濎垬鞚� $4,503,160.86毳� 鞏混棃雼り碃 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖鞚胳潃 氚滍枆須岇偓鞐� 甏�頃� 欷戩殧頃� 牍勱车臧� 攵�鞝曥爜 鞝曤炒臧� 鞛堧嫟瓿� 鞎岇 氇豁暅雼り碃 頇曥澑頃╇媹雼�.
Op茅ration d'initi茅 d'Idexx Laboratories divulgu茅e via le Form 144. Le dossier signale une proposition de vente de 1,200 actions ordinaires par l'interm茅diaire de Morgan Stanley Smith Barney pour une valeur de march茅 totale de $787,840.20. Les actions ont 茅t茅 acquises par exercice le 08/06/2025 et le paiement a 茅t茅 effectu茅 en esp猫ces. Sur 80,004,694 actions en circulation, la vente propos茅e repr茅sente environ 0.0015% du capital social ordinaire de la soci茅t茅.
Le dossier mentionne 茅galement trois ventes r茅alis茅es par NIMRATA K HUNT le 08/06/2025 totalisant 7,143 actions et des produits bruts de $4,503,160.86. Le d茅clarant affirme ne pas 锚tre au courant d'informations n茅gatives mat茅rielles non publiques concernant l'茅metteur.
Insider-Transaktion von Idexx Laboratories 眉ber Form 144 offengelegt. Die Meldung berichtet 眉ber einen vorgeschlagenen Verkauf von 1,200 Stammaktien 眉ber Morgan Stanley Smith Barney mit einem aggregierten Marktwert von $787,840.20. Die Aktien wurden durch Aus眉bung am 08/06/2025 erworben und bar bezahlt. Bei 80,004,694 ausstehenden Aktien entspricht der geplante Verkauf etwa 0.0015% des ausstehenden Stammkapitals des Unternehmens.
Die Meldung listet au脽erdem drei Verk盲ufe durch NIMRATA K HUNT am 08/06/2025 mit insgesamt 7,143 Aktien und Bruttoerl枚sen von $4,503,160.86. Der Melder best盲tigt, dass ihm keine wesentlichen nicht枚ffentlichen negativen Informationen 眉ber den Emittenten bekannt sind.
- Form 144 filed in compliance with Rule 144, providing broker, acquisition, and payment details as required.
- The proposed sale of 1,200 shares represents approximately 0.0015% of the 80,004,694 shares outstanding, which is immaterial to total capitalization.
- None.
Insights
TL;DR: Insider exercised options and is selling a small block 鈥� 1,200 shares worth $787,840 鈥� with related sales totaling 7,143 shares for $4.50M.
The filing documents a routine Rule 144 notice: acquisition by exercise on 08/06/2025 and a proposed brokered sale via Morgan Stanley Smith Barney. The primary metric is the size: 1,200 shares equals ~0.0015% of the 80,004,694 shares outstanding, which is immaterial to capitalization. Recent aggregated insider sales (7,143 shares, $4,503,160.86) are disclosed, but the filing gives no indication of undisclosed adverse facts. Impact on supply or market float is minimal based on stated figures.
TL;DR: Filing appears compliant with Rule 144; insider attests no undisclosed material adverse information.
The Form 144 provides required information: acquisition date, nature (exercised shares), payment method (cash), broker details, and recent insider sales. The attestation that the filer does not possess undisclosed material adverse information is standard and included. No governance red flags (e.g., sudden unexpected executive departure or regulatory disclosures) are present in the provided content. The disclosure supports procedural transparency rather than signaling material corporate change.
Operazione insider di Idexx Laboratories comunicata tramite Form 144. La comunicazione segnala la proposta vendita di 1,200 azioni ordinarie tramite Morgan Stanley Smith Barney per un valore di mercato complessivo di $787,840.20. Le azioni sono state acquisite mediante esercizio il 08/06/2025 e il pagamento 猫 stato effettuato in contanti. Con 80,004,694 azioni in circolazione, la vendita proposta rappresenta circa 0.0015% del capitale ordinario della societ脿.
La comunicazione riporta inoltre tre vendite a nome di NIMRATA K HUNT in data 08/06/2025 per un totale di 7,143 azioni e proventi lordi pari a $4,503,160.86. Il dichiarante afferma di non essere a conoscenza di informazioni riservate negative rilevanti sull'emittente.
Operaci贸n de insider de Idexx Laboratories divulgada mediante Form 144. El informe comunica la propuesta venta de 1,200 acciones ordinarias a trav茅s de Morgan Stanley Smith Barney por un valor de mercado agregado de $787,840.20. Las acciones se adquirieron mediante ejercicio el 08/06/2025 y el pago se realiz贸 en efectivo. Con 80,004,694 acciones en circulaci贸n, la venta propuesta representa aproximadamente el 0.0015% del capital social ordinario de la compa帽铆a.
El expediente tambi茅n recoge tres ventas efectuadas por NIMRATA K HUNT el 08/06/2025 por un total de 7,143 acciones y unos ingresos brutos de $4,503,160.86. El declarante afirma no tener conocimiento de informaci贸n adversa material no p煤blica sobre el emisor.
Form 144毳� 韱淀暣 瓿奠嫓霅� Idexx Laboratories 雮措秬鞛愱卑霝�. 鞝滌稖靹滊鞐� 霐半ゴ氅� Morgan Stanley Smith Barney毳� 韱淀暣 齑� 鞁滌灔臧�旃� $787,840.20 靸侂嫻鞚� 1,200 氤错喌欤� 毵り皝鞚� 鞝滌晥霅橃棃鞀惦媹雼�. 頃措嫻 欤检嫕鞚� 08/06/2025鞐� 頄夓偓毳� 韱淀暣 旆摑霅橃棃鞙茧┌ 雽�旮堨潃 順勱笀鞙茧 歆�攵堧悩鞐堨姷雼堧嫟. 氚滍枆欤检嫕 靾橁皜 80,004,694欤检澑 臧�鞖措嵃 鞝滌晥霅� 毵り皝鞚� 須岇偓 氤错喌欤� 齑濎垬鞚� 鞎� 0.0015%鞐� 頃措嫻頃╇媹雼�.
霕愴暅 鞝滌稖靹滊鞐愲姅 NIMRATA K HUNT臧� 08/06/2025鞐� 齑� 7,143欤茧ゼ 毵り皝頃橃棳 齑濎垬鞚� $4,503,160.86毳� 鞏混棃雼り碃 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖鞚胳潃 氚滍枆須岇偓鞐� 甏�頃� 欷戩殧頃� 牍勱车臧� 攵�鞝曥爜 鞝曤炒臧� 鞛堧嫟瓿� 鞎岇 氇豁暅雼り碃 頇曥澑頃╇媹雼�.
Op茅ration d'initi茅 d'Idexx Laboratories divulgu茅e via le Form 144. Le dossier signale une proposition de vente de 1,200 actions ordinaires par l'interm茅diaire de Morgan Stanley Smith Barney pour une valeur de march茅 totale de $787,840.20. Les actions ont 茅t茅 acquises par exercice le 08/06/2025 et le paiement a 茅t茅 effectu茅 en esp猫ces. Sur 80,004,694 actions en circulation, la vente propos茅e repr茅sente environ 0.0015% du capital social ordinaire de la soci茅t茅.
Le dossier mentionne 茅galement trois ventes r茅alis茅es par NIMRATA K HUNT le 08/06/2025 totalisant 7,143 actions et des produits bruts de $4,503,160.86. Le d茅clarant affirme ne pas 锚tre au courant d'informations n茅gatives mat茅rielles non publiques concernant l'茅metteur.
Insider-Transaktion von Idexx Laboratories 眉ber Form 144 offengelegt. Die Meldung berichtet 眉ber einen vorgeschlagenen Verkauf von 1,200 Stammaktien 眉ber Morgan Stanley Smith Barney mit einem aggregierten Marktwert von $787,840.20. Die Aktien wurden durch Aus眉bung am 08/06/2025 erworben und bar bezahlt. Bei 80,004,694 ausstehenden Aktien entspricht der geplante Verkauf etwa 0.0015% des ausstehenden Stammkapitals des Unternehmens.
Die Meldung listet au脽erdem drei Verk盲ufe durch NIMRATA K HUNT am 08/06/2025 mit insgesamt 7,143 Aktien und Bruttoerl枚sen von $4,503,160.86. Der Melder best盲tigt, dass ihm keine wesentlichen nicht枚ffentlichen negativen Informationen 眉ber den Emittenten bekannt sind.
FAQ
What does the Form 144 for Idexx (IDXX) report?
Who is the seller named in the filing?
When were the securities acquired and how were they paid for?
How many shares were sold by the insider in the past three months per the filing?
What portion of outstanding shares does the proposed 1,200-share sale represent?
